z-logo
open-access-imgOpen Access
Retinoid X receptor gamma signaling accelerates CNS remyelination
Author(s) -
Jeffrey K. Huang,
Andrew A. Jarjour,
Brahim NaitOumesmar,
Christophe Kerni,
Anna Williams,
Wojciech Krężel,
Hiroyuki Kagechika,
Julien Bauer,
Chao Zhao,
Anne BaronVan Evercooren,
Pierre Chambon,
Charles ffrenchConstant,
Robin J.M. Franklin
Publication year - 2010
Publication title -
nature neuroscience
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 13.403
H-Index - 422
eISSN - 1546-1726
pISSN - 1097-6256
DOI - 10.1038/nn.2702
Subject(s) - remyelination , oligodendrocyte , biology , retinoid x receptor , retinoic acid , multiple sclerosis , myelin , neuroscience , microbiology and biotechnology , central nervous system , nuclear receptor , immunology , transcription factor , cell culture , biochemistry , genetics , gene
The molecular basis of CNS myelin regeneration (remyelination) is poorly understood. We generated a comprehensive transcriptional profile of the separate stages of spontaneous remyelination that follow focal demyelination in the rat CNS and found that transcripts that encode the retinoid acid receptor RXR-γ were differentially expressed during remyelination. Cells of the oligodendrocyte lineage expressed RXR-γ in rat tissues that were undergoing remyelination and in active and remyelinated multiple sclerosis lesions. Knockdown of RXR-γ by RNA interference or RXR-specific antagonists severely inhibited oligodendrocyte differentiation in culture. In mice that lacked RXR-γ, adult oligodendrocyte precursor cells efficiently repopulated lesions after demyelination, but showed delayed differentiation into mature oligodendrocytes. Administration of the RXR agonist 9-cis-retinoic acid to demyelinated cerebellar slice cultures and to aged rats after demyelination caused an increase in remyelinated axons. Our results indicate that RXR-γ is a positive regulator of endogenous oligodendrocyte precursor cell differentiation and remyelination and might be a pharmacological target for regenerative therapy in the CNS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom